127 related articles for article (PubMed ID: 25993689)
1. Use of Intravenous Immunoglobulin for Patients with Inflammatory Bowel Disease with Contraindications or Who Are Unresponsive to Conventional Treatments.
Merkley SA; Beaulieu DB; Horst S; Duley C; Annis K; Nohl A; Schwartz DA
Inflamm Bowel Dis; 2015 Aug; 21(8):1854-9. PubMed ID: 25993689
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and Factors Associated with Treatment Response of Intravenous Immunoglobulin in Inpatients with Refractory Inflammatory Bowel Diseases.
Horton N; Kochhar G; Patel K; Lopez R; Shen B
Inflamm Bowel Dis; 2017 Jul; 23(7):1080-1087. PubMed ID: 28452863
[TBL] [Abstract][Full Text] [Related]
3. Treatment with intravenous immunoglobulins in systemic lupus erythematosus: a series of 52 patients from a single centre.
Camara I; Sciascia S; Simoes J; Pazzola G; Salas V; Karim Y; Roccatello D; Cuadrado MJ
Clin Exp Rheumatol; 2014; 32(1):41-7. PubMed ID: 24029366
[TBL] [Abstract][Full Text] [Related]
4. Intravenous immunoglobulin for the treatment of severe Clostridium difficile colitis: an observational study and review of the literature.
Abougergi MS; Broor A; Cui W; Jaar BG
J Hosp Med; 2010 Jan; 5(1):E1-9. PubMed ID: 20063275
[TBL] [Abstract][Full Text] [Related]
5. Usefulness of high-dose intravenous human immunoglobulins treatment for refractory recurrent pericarditis.
Moretti M; Buiatti A; Merlo M; Massa L; Fabris E; Pinamonti B; Sinagra G
Am J Cardiol; 2013 Nov; 112(9):1493-8. PubMed ID: 23972350
[TBL] [Abstract][Full Text] [Related]
6. Clinical experience with polyclonal IgM-enriched immunoglobulins in a group of patients affected by sepsis after cardiac surgery.
Buda S; Riefolo A; Biscione R; Goretti E; Cattabriga I; Grillone G; Bacchi-Reggiani L; Pacini D
J Cardiothorac Vasc Anesth; 2005 Aug; 19(4):440-5. PubMed ID: 16085247
[TBL] [Abstract][Full Text] [Related]
7. First line treatment of pemphigus vulgaris with a novel protocol in patients with contraindications to systemic corticosteroids and immunosuppressive agents: Preliminary retrospective study with a seven year follow-up.
Ahmed AR; Nguyen T; Kaveri S; Spigelman ZS
Int Immunopharmacol; 2016 May; 34():25-31. PubMed ID: 26919279
[TBL] [Abstract][Full Text] [Related]
8. Patients with Refractory Crohn's Disease Successfully Treated with Ustekinumab.
Harris KA; Horst S; Gadani A; Nohl A; Annis K; Duley C; Beaulieu D; Ghazi L; Schwartz DA
Inflamm Bowel Dis; 2016 Feb; 22(2):397-401. PubMed ID: 26752468
[TBL] [Abstract][Full Text] [Related]
9. Evaluating dose ratio of subcutaneous to intravenous immunoglobulin therapy among patients with primary immunodeficiency disease switching to 20% subcutaneous immunoglobulin therapy.
Krishnarajah G; Lehmann JK; Ellman B; Bhak RH; DerSarkissian M; Leader D; Bullinger AL; Sheng Duh M
Am J Manag Care; 2016 Oct; 22(15 Suppl):s475-s481. PubMed ID: 27849353
[TBL] [Abstract][Full Text] [Related]
10. [Multifocal motor neuropathy: a retrospective study of the response to high-dose intravenous immunoglobulin (IVIg) and current perspectives for diagnosis and treatment].
Léger JM; Viala K; Maisonobe T; Bouche P
Bull Acad Natl Med; 2007 Oct; 191(7):1395-407; discussion 1407-9. PubMed ID: 18447061
[TBL] [Abstract][Full Text] [Related]
11. The potential impact of substitutive therapy with intravenous immunoglobulin on the outcome of heart transplant recipients with infections.
Carbone J; Sarmiento E; Palomo J; Fernandez-Yañez J; Muñoz P; Bouza E; Rodríguez-Molina J; Lanio N; Fernandez-Cruz E
Transplant Proc; 2007 Sep; 39(7):2385-8. PubMed ID: 17889198
[TBL] [Abstract][Full Text] [Related]
12. The use of sirolimus (rapamycin) in the management of refractory inflammatory bowel disease in children.
Mutalib M; Borrelli O; Blackstock S; Kiparissi F; Elawad M; Shah N; Lindley K
J Crohns Colitis; 2014 Dec; 8(12):1730-4. PubMed ID: 25240477
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic Drug Monitoring to Guide Infliximab Dose Adjustment is Associated with Better Endoscopic Outcomes than Clinical Decision Making Alone in Active Inflammatory Bowel Disease.
Kelly OB; Donnell SO; Stempak JM; Steinhart AH; Silverberg MS
Inflamm Bowel Dis; 2017 Jul; 23(7):1202-1209. PubMed ID: 28498155
[TBL] [Abstract][Full Text] [Related]
14. The effect of intravenous immunoglobulin (IVIG) treatment on patients with dermatomyositis: a 4-year follow-up study.
Kampylafka EI; Kosmidis ML; Panagiotakos DB; Dalakas M; Moutsopoulos HM; Tzioufas AG
Clin Exp Rheumatol; 2012; 30(3):397-401. PubMed ID: 22510247
[TBL] [Abstract][Full Text] [Related]
15. Intravenous immunoglobulin therapy in patients with multiple mucosal involvement in mucous membrane pemphigoid.
Sami N; Bhol KC; Razzaque Ahmed A
Clin Immunol; 2002 Jan; 102(1):59-67. PubMed ID: 11781068
[TBL] [Abstract][Full Text] [Related]
16. Intravenous immunoglobulin as short- and long-term therapy of multifocal motor neuropathy: a retrospective study of response to IVIg and of its predictive criteria in 40 patients.
Léger JM; Viala K; Cancalon F; Maisonobe T; Gruwez B; Waegemans T; Bouche P
J Neurol Neurosurg Psychiatry; 2008 Jan; 79(1):93-6. PubMed ID: 18079302
[TBL] [Abstract][Full Text] [Related]
17. Experimental study on the use of intravenous immunoglobulin (IVIg) in patients with steroid-resistant Crohn's disease.
Chrissafidou A; Malek M; Musch E
Z Gastroenterol; 2007 Jul; 45(7):605-8. PubMed ID: 17620224
[TBL] [Abstract][Full Text] [Related]
18. Persistent or Recurrent Anemia Is Associated With Severe and Disabling Inflammatory Bowel Disease.
Koutroubakis IE; Ramos-Rivers C; Regueiro M; Koutroumpakis E; Click B; Schoen RE; Hashash JG; Schwartz M; Swoger J; Baidoo L; Barrie A; Dunn MA; Binion DG
Clin Gastroenterol Hepatol; 2015 Oct; 13(10):1760-6. PubMed ID: 25862987
[TBL] [Abstract][Full Text] [Related]
19. Prevention of thrombosis relapse in antiphospholipid syndrome patients refractory to conventional therapy using intravenous immunoglobulin.
Sciascia S; Giachino O; Roccatello D
Clin Exp Rheumatol; 2012; 30(3):409-13. PubMed ID: 22513222
[TBL] [Abstract][Full Text] [Related]
20. Intravenous immunoglobulin therapy in the treatment of patients with pemphigus vulgaris unresponsive to conventional immunosuppressive treatment.
Ahmed AR
J Am Acad Dermatol; 2001 Nov; 45(5):679-90. PubMed ID: 11606916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
